Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 3/2012

01.03.2012 | Fertility Preservation

Live birth from oocytes cryopreserved with slow-freezing protocol and thawed after 6 years of storage

verfasst von: Giovanni Battista La Sala, Francesco Capodanno, Barbara Valli, Ilaria Rondini, Maria Teresa Villani, Alessia Nicoli

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Excerpt

After the birth of more than 900 babies from human cryopreserved oocytes with no apparent increase in congenital anomalies compared to conventional IVF babies [1], oocyte cryopreservation has become a quite widespread technique in Assisted Reproductive Technologies (ART), even in the female fertility preservation programs. Today two procedures are available for oocyte cryopreservation: slow-freezing (SF), the first protocol introduced, and vitrification (VT) [2]. The main goal of VT is to achieve high cryoprotectant concentration in order to increase the viscosity of the cryoprotectant solution and to suppress ice nucleation [3]. Biological and clinical outcomes of SF protocols seem to be less than those obtained with fresh and vitrified oocytes [46]. Oocyte cryopreservation is usually used in ART laboratories for supernumerary oocyte storage after Controlled Ovarian Stimulation (COS) [4], prevention of Ovarian HyperStimulation Syndrome (OHSS) risk, oocyte accumulation in poor responder patients [7], and fertility preservation programmes for cancer patients [810] or for social reasons [11]. Nevertheless, in 2008 the Practice Committee of American Society of Reproductive Medicine (ASRM) concluded that “Oocyte cryopreservation presently should be considered an experimental technique,” as the data available on the efficacy of oocyte cryopreservation in relation to the length of storage are still limited [1,12]. Instead, the ASRM considers embryo cryopreservation a non-experimental technique [12], with a proven clinical outcome regardless of the length of storage [13,14]. Unfortunately, there are limited data concerning children born from long-term cryopreserved oocytes [1]. The first live birth obtained from oocytes stored for a long period was reported by Yang et al. in 2007: oocytes were cryopreserved by SF for fertility preservation before cancer treatment and thawed 6 years later . In 2008, Parmegiani et al. reported a live birth from oocytes cryopreserved by SF after 5 years of storage in a patient who underwent infertility treatment. Kim and Hong [17] recently described a similar result, reporting a live baby born from vitrified oocytes thawed 5 years later . …
Literatur
1.
Zurück zum Zitat Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009;18:769–76.PubMedCrossRef Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online. 2009;18:769–76.PubMedCrossRef
2.
Zurück zum Zitat Gook DA. History of oocyte cryopreservation. 2010;23:281–9. Gook DA. History of oocyte cryopreservation. 2010;23:281–9.
3.
Zurück zum Zitat Boldt J. Current results with slow freezing and vitrification of the human oocyte. Reprod Biomed Online. 2010;23:314–22.PubMedCrossRef Boldt J. Current results with slow freezing and vitrification of the human oocyte. Reprod Biomed Online. 2010;23:314–22.PubMedCrossRef
4.
Zurück zum Zitat Borini A, Levi Setti PE, Anserini P, De Luca R, De Santis L, Porcu E, La Sala GB, Ferraretti A, Bartolotti T, Coticchio G, Scaravelli G. Multicenter observational study on slow-cooling oocyte cryopreservation: clinical outcome. Fertil Steril. 2010;94:1662–8.PubMedCrossRef Borini A, Levi Setti PE, Anserini P, De Luca R, De Santis L, Porcu E, La Sala GB, Ferraretti A, Bartolotti T, Coticchio G, Scaravelli G. Multicenter observational study on slow-cooling oocyte cryopreservation: clinical outcome. Fertil Steril. 2010;94:1662–8.PubMedCrossRef
5.
Zurück zum Zitat Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2011;96:277–85.PubMedCrossRef Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2011;96:277–85.PubMedCrossRef
6.
Zurück zum Zitat Grifo JA, Noyes N. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients. Fertil Steril. 2010;93:391–6.PubMedCrossRef Grifo JA, Noyes N. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients. Fertil Steril. 2010;93:391–6.PubMedCrossRef
7.
Zurück zum Zitat Milán M, Cobo AC, Rodrigo L, Mateu E, Mercader A, Buendía P, Peinado V, Delgado A, Mir P, Simón C, Remohí J, Pellicer A, Rubio C. Redefining advanced maternal age as an indication for preimplantation genetic screening. Reprod Biomed Online. 2010;21:649–57.PubMedCrossRef Milán M, Cobo AC, Rodrigo L, Mateu E, Mercader A, Buendía P, Peinado V, Delgado A, Mir P, Simón C, Remohí J, Pellicer A, Rubio C. Redefining advanced maternal age as an indication for preimplantation genetic screening. Reprod Biomed Online. 2010;21:649–57.PubMedCrossRef
8.
Zurück zum Zitat Noyes N, Labella PA, Grifo J, Knopman JM. Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors. J Assist Reprod Genet. 2010;27:495–9.PubMedCrossRef Noyes N, Labella PA, Grifo J, Knopman JM. Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors. J Assist Reprod Genet. 2010;27:495–9.PubMedCrossRef
9.
Zurück zum Zitat Noyes N, Knopman JM, Melzer K, Fino ME, Friedman B, Westphal LM. Oocyte cryopreservation as a fertility preservation measure for cancer patients. Reprod Biomed Online. 2011;23:323–33.PubMedCrossRef Noyes N, Knopman JM, Melzer K, Fino ME, Friedman B, Westphal LM. Oocyte cryopreservation as a fertility preservation measure for cancer patients. Reprod Biomed Online. 2011;23:323–33.PubMedCrossRef
10.
Zurück zum Zitat Cobo A, Domingo J, Pérez S, Crespo J, Remohí J, Pellicer A. Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol. 2008;10:268–73.PubMedCrossRef Cobo A, Domingo J, Pérez S, Crespo J, Remohí J, Pellicer A. Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol. 2008;10:268–73.PubMedCrossRef
11.
Zurück zum Zitat Stoop D, Nekkebroeck J, Devroey P. A survey on the intentions and attitudes towards oocyte cryopreservation for non-medical reasons among women of reproductive age. Hum Reprod. 2011;26:655–61.PubMedCrossRef Stoop D, Nekkebroeck J, Devroey P. A survey on the intentions and attitudes towards oocyte cryopreservation for non-medical reasons among women of reproductive age. Hum Reprod. 2011;26:655–61.PubMedCrossRef
12.
Zurück zum Zitat Practice Committee of American Society for Reproductive Medicine; Practice Committee of Society for Assisted Reproductive Technology. Ovarian tissue and oocyte cryopreservation. Fertil Steril. 2008;90:S241–6. Practice Committee of American Society for Reproductive Medicine; Practice Committee of Society for Assisted Reproductive Technology. Ovarian tissue and oocyte cryopreservation. Fertil Steril. 2008;90:S241–6.
13.
Zurück zum Zitat Riggs R, Mayer J, Dowling-Lacey D, Chi TF, Jones E, Oehninger S. Does storage time influence postthaw survival and pregnancy outcome? An analysis of 11,768 cryopreserved human embryos. Fertil Steril. 2010;93:109–15.PubMedCrossRef Riggs R, Mayer J, Dowling-Lacey D, Chi TF, Jones E, Oehninger S. Does storage time influence postthaw survival and pregnancy outcome? An analysis of 11,768 cryopreserved human embryos. Fertil Steril. 2010;93:109–15.PubMedCrossRef
14.
Zurück zum Zitat Check JH, Summers-Chase D, Yuan W, Swenson K, Horwath D. Length of time of embryo storage does not negatively influence pregnancy rates after thawing and transfer. Clin Exp Obstet Gynecol. 2010;37:185–6.PubMed Check JH, Summers-Chase D, Yuan W, Swenson K, Horwath D. Length of time of embryo storage does not negatively influence pregnancy rates after thawing and transfer. Clin Exp Obstet Gynecol. 2010;37:185–6.PubMed
15.
Zurück zum Zitat Yang D, Brown SE, Nguyen K, Reddy V, Brubaker C, Winslow KL. Live birth after the transfer of human embryos developed from cryopreserved oocytes harvested before cancer treatment. Fertil Steril. 2007;87:1469e1–4.CrossRef Yang D, Brown SE, Nguyen K, Reddy V, Brubaker C, Winslow KL. Live birth after the transfer of human embryos developed from cryopreserved oocytes harvested before cancer treatment. Fertil Steril. 2007;87:1469e1–4.CrossRef
16.
Zurück zum Zitat Parmegiani L, Fabbri R, Cognigni GE, Bernardi S, Pocognoli P, Filicori M. Blastocyst formation, pregnancy, and birth derived from human oocytes cryopreserved for 5 years. Fertil Steril. 2008;90:2014.e7–2014.e10.CrossRef Parmegiani L, Fabbri R, Cognigni GE, Bernardi S, Pocognoli P, Filicori M. Blastocyst formation, pregnancy, and birth derived from human oocytes cryopreserved for 5 years. Fertil Steril. 2008;90:2014.e7–2014.e10.CrossRef
17.
Zurück zum Zitat Kim TJ, Hong SW. Successful live birth from vitrified oocytes after 5 years of cryopreservation. J Assist Reprod Genet. 2011;2011(28):73–6.CrossRef Kim TJ, Hong SW. Successful live birth from vitrified oocytes after 5 years of cryopreservation. J Assist Reprod Genet. 2011;2011(28):73–6.CrossRef
18.
Zurück zum Zitat Ragni G, Allegra A, Anserini P, Causio F, Ferraretti AP, Greco E, Palermo R, Somigliana E. The 2004 Italian legislation regulating assisted reproduction technology: a multicentre survey on the results of IVF cycles. Hum Reprod. 2005;20:2224–8.PubMedCrossRef Ragni G, Allegra A, Anserini P, Causio F, Ferraretti AP, Greco E, Palermo R, Somigliana E. The 2004 Italian legislation regulating assisted reproduction technology: a multicentre survey on the results of IVF cycles. Hum Reprod. 2005;20:2224–8.PubMedCrossRef
19.
Zurück zum Zitat Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992;4:17–8.CrossRef Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet. 1992;4:17–8.CrossRef
20.
Zurück zum Zitat La Sala GB, Nicoli A, Villani MT, Pescarini M, Gallinelli A, Blickstein I. Outcome of 518 salvage oocyte-cryopreservation cycles performed as a routine procedure in an in vitro fertilization program. Fertil Steril. 2006;86:1423–7.PubMedCrossRef La Sala GB, Nicoli A, Villani MT, Pescarini M, Gallinelli A, Blickstein I. Outcome of 518 salvage oocyte-cryopreservation cycles performed as a routine procedure in an in vitro fertilization program. Fertil Steril. 2006;86:1423–7.PubMedCrossRef
21.
Zurück zum Zitat Fabbri R, Porcu E, Marsella T, Rocchetta G, Venturoli S, Flamigni C. Human oocyte cryopreservation: new perspectives regarding oocyte survival. Hum Reprod. 2001;16:411–6.PubMedCrossRef Fabbri R, Porcu E, Marsella T, Rocchetta G, Venturoli S, Flamigni C. Human oocyte cryopreservation: new perspectives regarding oocyte survival. Hum Reprod. 2001;16:411–6.PubMedCrossRef
22.
Zurück zum Zitat Leibo SP, Pool TB. The principal variables of cryopreservation: solutions, temperatures, and rate changes. Fertil Steril. 2011;96:269–76.PubMedCrossRef Leibo SP, Pool TB. The principal variables of cryopreservation: solutions, temperatures, and rate changes. Fertil Steril. 2011;96:269–76.PubMedCrossRef
23.
Metadaten
Titel
Live birth from oocytes cryopreserved with slow-freezing protocol and thawed after 6 years of storage
verfasst von
Giovanni Battista La Sala
Francesco Capodanno
Barbara Valli
Ilaria Rondini
Maria Teresa Villani
Alessia Nicoli
Publikationsdatum
01.03.2012
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 3/2012
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-011-9702-x

Weitere Artikel der Ausgabe 3/2012

Journal of Assisted Reproduction and Genetics 3/2012 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.